Related Experiment Videos
Hydrochlorothiazide-induced pulmonary edema and associated immunologic changes.
1Department of Internal Medicine, Miami Veterans Administration Medical Center, FL, USA.
The Annals of Pharmacotherapy
|March 20, 1999
Summary
Hydrochlorothiazide can cause noncardiogenic pulmonary edema through an immune response. This rare reaction involves granulocytic infiltration and IgG deposition in the lungs, suggesting an immunologic mechanism.
Area of Science:
- Pharmacology
- Immunology
- Pulmonology
Background:
- Hydrochlorothiazide is a common diuretic.
- Acute pulmonary edema is a serious adverse reaction.
- The exact mechanism of hydrochlorothiazide-induced pulmonary edema is not fully understood.
Observation:
- A 66-year-old woman developed acute pulmonary edema shortly after taking hydrochlorothiazide.
- Laboratory findings included hemoconcentration, altered white blood cell counts, and changes in immunoglobulin and complement levels.
- These changes suggest an immune system involvement.
Findings:
- The patient's reaction presented with specific immunological markers.
- These markers, including granulocytic infiltration and IgG deposition, point towards an immune-mediated process.
- This case adds to the understanding of hydrochlorothiazide's potential adverse effects.
Implications:
- Noncardiogenic pulmonary edema can be a rare, idiosyncratic reaction to hydrochlorothiazide.
- An immunologic mechanism may underlie this adverse drug reaction.
- Further research is needed to elucidate the precise role of immune pathways in hydrochlorothiazide toxicity.